Bearish flow noted in Verve Therapeutics (VERV) with 4,217 puts trading, or 1.1x expected. Most active are Nov-25 10 puts and Aug-25 11 puts, with total volume in those strikes near 3,600 contracts. The Put/Call Ratio is 31.24, while ATM IV is up nearly 2 points on the day. Earnings are expected on August 14th.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VERV:
- JonesResearch lists factors for Prime Medicine continued share rally
- Hold Rating Issued for Verve Therapeutics Amid Eli Lilly Acquisition and Uncertain Milestones
- Verve Therapeutics downgraded to Market Perform from Outperform at BMO Capital
- Crispr posts strong CTX310 data, says Chardan
- Eli Lilly (LLY) Enters Gene-Editing Space with Verve Therapeutics Acquisition